Why the study?
Does the presence of pre-discharge mitral regurgitation predict 2-year mortality and decompensated heart failure in patients admitted for myocardial infarction?
Does the presence of pre-discharge mitral regurgitation predict 2-year mortality and decompensated heart failure in patients admitted for myocardial infarction?
Answers are grounded in this paper and cite their sources.
Even mild ischemic mitral regurgitation prior to discharge in MI patients is an independent predictor of 2-year mortality and decompensated heart failure, adding prognostic value to the GRACE score.
AIMS: Ischemic Mitral Regurgitation (MR) has early prognostic impact in Myocardial Infarction (MI). Its medium-term importance, especially of mild MR, has not been established. PURPOSE: to determine new clinical/analytical predictors of MR in MI-patients and establish its prognostic value during two-year follow-up [endpoints: mortality, decompensated heart failure (dHF)]. METHODS AND RESULTS: 796 patients admitted for MI (age 68.8±13.4, 63.2% males, 44.6% STEMI). DATA: Admission analytical study, risk scores, coronariography, pre-discharge echocardiogram. Patients followed for two years. Clinical/analytical predictors of pre-discharge MR assessed. Predictive model for presence of pre-discharge MR included GRACE for intra-hospital mortality [IHM](OR=1.008, p<0.001), glomerular filtration rate (GFR)[OR=0.993, p=0.048], admission haemoglobin (OR=0.84, p=0.003). In univariate analysis, moderate-severe MR predicted 2-year mortality (OR=3.32, p<0.001), but not dHF. Two year mortality rate was proportional to severity of pre-discharge MR. Mild MR (vs. no MR) associated with higher risk for 2-year mortality (OR=2.04, p=0.014) and re-admission for dHF (OR=2.55, p=0.001). Predictive model for 2-year mortality included MR severity (OR=1.42, p=0.033) and GRACE for IHM (OR=1.023, p<0.001). CONCLUSION: GRACE score for IHM, GFR and admission haemoglobin independently predicted risk for pre-discharge MR. MR, including its milder form, was an independent predictor of 2-year mortality, adding prognostic power to GRACE score.
No takes yet. Share an insight, caveat, or question.
Barra et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: